| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Department of Bone Biology, Merck, Sharp, and Dohme Research Laboratories West Point, Pennsylvania 19486
Address requests for reprints to: Dr. Gideon A. Rodan, Department of Bone Biology, Merck, Sharp, and Dohme Research Laboratories, West Point, Pennsylvania 19486.
Abstract
Although a small number of estrogen receptors (ER) were visualized in osteoblastic cells, and estradiol (E2) has some effects on osteoblasts in vitro, the direct action of E2 on osteoblasts has not been fully established. To determine the presence of functional ER in osteoblasts, we transfected cells with a plasmid containing the chloramphenicol acetyl transferase (CAT) reporter gene and the estrogen-responsive element (ERE) from the vitellogenin A2 gene. E2-dependent induction of CAT activity was determined 48 h after transient transfection and subsequent treatment with 10–100 nM 17β-E2. 17β-E2, but not 17
-E2, dihydrotestosterone, or progesterone, induced CAT activity in a dose-dependent manner (up to 6-fold) in rat calvarial fraction-3, RCT-3, PyMS, and UMR-106 cells as well as in the human osteosarcoma cell line SaOS-2/B-10. In contrast, E2 had no effect on the induction of CAT activity in the preosteoblastic cell lines RCT-1 and TRAB-11, in the rat osteosarcoma cell line ROS 17/2.8, and in the fibroblastic cell lines BALB-c/3T3 and NRK. Overexpression of ER using a simian virus-40-based expression vector not only conferred or enhanced E2-dependent induction of CAT in all cell types, but augmented E2-dependent expression of insulin-like growth factor-I and E2-stimulated DNA synthesis in primary calvarial and PyMS osteoblastic cells, respectively. These data show the presence of low levels of functional endogenous ER in some, but not all, osteoblastic cells and suggest that the abundance of ER may be rate limiting in the action of E2 on these cells.
FOOTNOTES
* Present address: Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria 3050, Australia.
Present address: Molecular Endocrinology Laboratory, Imperial Cancer Research Fund, London, WC2A 3PX United Kingdom.
Received for publication April 23, 1989. Revision received August 19, 1991. Accepted for publication August 20, 1991.
This article has been cited by other articles:
![]() |
J. Liu, K. S. Knappenberger, H. Kack, G. Andersson, E. Nilsson, C. Dartsch, and C. W. Scott A Homogeneous in Vitro Functional Assay for Estrogen Receptors: Coactivator Recruitment Mol. Endocrinol., March 1, 2003; 17(3): 346 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge Estrogen receptor interaction with estrogen response elements Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. N. Bodine, R. A. Henderson, J. Green, M. Aronow, T. Owen, G. S. Stein, J. B. Lian, and B. S. Komm Estrogen Receptor-{alpha} Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression Endocrinology, April 1, 1998; 139(4): 2048 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Balica, K. Bostrom, V. Shin, K. Tillisch, and L. L. Demer Calcifying Subpopulation of Bovine Aortic Smooth Muscle Cells Is Responsive to 17ß-Estradiol Circulation, April 1, 1997; 95(7): 1954 - 1960. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |